Galit Levi Dunietz1, Ronald D Chervin2, James F Burke3, Tiffany J Braley3. 1. Division of Sleep Medicine, Department of Neurology, University of Michigan, Ann Arbor, Michigan. Electronic address: gldt@med.umich.edu. 2. Division of Sleep Medicine, Department of Neurology, University of Michigan, Ann Arbor, Michigan. 3. Department of Neurology, University of Michigan, Ann Arbor, Michigan.
Abstract
OBJECTIVE: The objective of the study was to characterize obstructive sleep apnea treatment patterns among older Americans with neurological conditions. SETTING AND PARTICIPANTS: Claims data from a 5% fee-for-service sample of Medicare beneficiaries were analyzed to determine the proportion of older adults with OSA who received and were adherent to continuous positive airway pressure therapy and examine potential gaps in OSA care among neurological populations. Logistic regression was used to determine whether gender or race/ethnicity modified the associations between neurological morbidities and OSA treatment or adherence. RESULTS: Data from n = 102,618 beneficiaries with OSA were identified. The prevalence of stroke, cognitive disorders, or Parkinson's disease in this sample was 7%, 3%, and 2% respectively. Overall, OSA-diagnosed individuals (73%) obtained treatment, and most treated were adherent to CPAP (72%). Lower proportions of OSA treatment and adherence were observed in neurological conditions, particularly stroke. In logistic regression models, gender and race/ethnicity each modified associations between neurological comorbidity and OSA treatment and adherence. Women as compared to men with a given neurological condition were uniformly less likely to receive CPAP or adhere to treatment (P < .01 for each condition). Similarly, in comparison to whites with the same neurological condition, OSA treatment was significantly lower among all other races with stroke, and among blacks with cognitive disorders. CONCLUSIONS: Older women and minorities with neurological conditions may be more vulnerable to gaps in OSA care. Targeted strategies to improve treatment disparities and neurological outcomes in older adults could be informed by these data.
OBJECTIVE: The objective of the study was to characterize obstructive sleep apnea treatment patterns among older Americans with neurological conditions. SETTING AND PARTICIPANTS: Claims data from a 5% fee-for-service sample of Medicare beneficiaries were analyzed to determine the proportion of older adults with OSA who received and were adherent to continuous positive airway pressure therapy and examine potential gaps in OSA care among neurological populations. Logistic regression was used to determine whether gender or race/ethnicity modified the associations between neurological morbidities and OSA treatment or adherence. RESULTS: Data from n = 102,618 beneficiaries with OSA were identified. The prevalence of stroke, cognitive disorders, or Parkinson's disease in this sample was 7%, 3%, and 2% respectively. Overall, OSA-diagnosed individuals (73%) obtained treatment, and most treated were adherent to CPAP (72%). Lower proportions of OSA treatment and adherence were observed in neurological conditions, particularly stroke. In logistic regression models, gender and race/ethnicity each modified associations between neurological comorbidity and OSA treatment and adherence. Women as compared to men with a given neurological condition were uniformly less likely to receive CPAP or adhere to treatment (P < .01 for each condition). Similarly, in comparison to whites with the same neurological condition, OSA treatment was significantly lower among all other races with stroke, and among blacks with cognitive disorders. CONCLUSIONS: Older women and minorities with neurological conditions may be more vulnerable to gaps in OSA care. Targeted strategies to improve treatment disparities and neurological outcomes in older adults could be informed by these data.
Authors: Martha E Billings; Dennis Auckley; Ruth Benca; Nancy Foldvary-Schaefer; Conrad Iber; Susan Redline; Carol L Rosen; Phyllis Zee; Vishesh K Kapur Journal: Sleep Date: 2011-12-01 Impact factor: 5.849
Authors: Hiraku Kumamaru; Suzanne E Judd; Jeffrey R Curtis; Rekha Ramachandran; N Chantelle Hardy; J David Rhodes; Monika M Safford; Brett M Kissela; George Howard; Jessica J Jalbert; Thomas G Brott; Soko Setoguchi Journal: Circ Cardiovasc Qual Outcomes Date: 2014-06-24
Authors: Carin Sahlin; Olov Sandberg; Yngve Gustafson; Gösta Bucht; Bo Carlberg; Hans Stenlund; Karl A Franklin Journal: Arch Intern Med Date: 2008-02-11
Authors: Tiffany J Braley; Galit Levi Dunietz; Ronald D Chervin; Lynda D Lisabeth; Lesli E Skolarus; James F Burke Journal: J Am Geriatr Soc Date: 2018-05-09 Impact factor: 5.562
Authors: Alison McMillan; Daniel J Bratton; Rita Faria; Magda Laskawiec-Szkonter; Susan Griffin; Robert J Davies; Andrew J Nunn; John R Stradling; Renata L Riha; Mary J Morrell Journal: Lancet Respir Med Date: 2014-08-26 Impact factor: 30.700
Authors: Monica Moon Shieu; Afsara Zaheed; Carol Shannon; Ronald David Chervin; Alan Conceicao; Henry Lauris Paulson; Tiffany Joy Braley; Galit Levi Dunietz Journal: Neurology Date: 2022-05-06 Impact factor: 11.800
Authors: Galit Levi Dunietz; Yue Yu; Rivkah S Levine; Alan S Conceicao; James F Burke; Ronald D Chervin; Tiffany J Braley Journal: J Clin Sleep Med Date: 2021-03-01 Impact factor: 4.062
Authors: Priya V Borker; Emely Carmona; Utibe R Essien; Gul Jana Saeed; S Mehdi Nouraie; Jessie P Bakker; Christy J Stitt; Mark S Aloia; Sanjay R Patel Journal: Am J Respir Crit Care Med Date: 2021-08-01 Impact factor: 30.528
Authors: Christopher N Kaufmann; Mark W Bondi; Wesley K Thompson; Adam P Spira; Sonia Ancoli-Israel; Atul Malhotra Journal: J Gerontol A Biol Sci Med Sci Date: 2022-03-03 Impact factor: 6.591